Detection of mismatches by cleavage of nucleic acid heteroduplexes

• US 5,824,471 A
• Filed: 06/05/1995
• Issued: 10/20/1998
• Est. Priority Date: 06/05/1995
• Status: Expired due to Fees

• Current Assignee: Brigham and Women's Hospital Incorporated, Dana-Farber Cancer Institute
• Original Assignee: Brigham and Women's Hospital Incorporated, Dana-Farber Cancer Institute
• Inventors: Kolodner, Richard, Mashal, Robert, Sklar, Jeffrey
• Primary Examiner(s): Jones, W. Gary
• Assistant Examiner(s): Atzel, Amy
• Application Number:
  US08/460,899
• Time in Patent Office: 1,233 Days
• Field of Search: 435/6, 435/91.2, 435/183, 435/195, 435/196, 536/23.1, 935/77, 935/78
• US Class Current: 435/6.13
• CPC Class Codes: C12Q 1/683 involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]

Abstract

Novel methods and kits for detecting mismatches in nucleic acids using one or more resolvase enzymes. These methods can be used in medical procedures or research, veterinary procedures or research, agricultural applications, forensics, and paternity testing. For example, in forensics and paternity testing, methods of the invention can replace or complement RFLP mapping.

Claims

1. A method of detecting a mismatch between a first nucleic acid strand and a second nucleic acid strand comprising:

forming a plurality of duplexes, each duplex including a molecule of said first nucleic acid strand, or a portion thereof, and a molecule of said second nucleic acid strand, or a portion thereof;

contacting a first bacteriophage resolvase and a second bacteriophage resolvase with said plurality of duplexes, wherein said first and said second resolvases are different;

determining if said plurality of duplexes is cleaved by either or both of said first and said second resolvases, wherein cleavage indicates the presence of a mismatch.

2. The method of claim 1, wherein said first strand is derived from a subject at risk for a mutation and the second strand has a wild-type sequence for said mutation.

3. The method of claim 2, wherein said second strand is derived from the subject at risk for a mutation.

4. The method of claim 2, wherein said second strand is derived from a subject not at risk for a mutation or for a disorder associated with a mutation.

5. The method of claim 1, wherein said first bacteriophage resolvase is bacteriophage T4 endonuclease VII.

6. The method of claim 1, wherein said second bacteriophage resolvase is bacteriophage T7 endonuclease I.

7. The method of claim 1, wherein said first bacteriophage resolvase and said second bacteriophage resolvase cleave at a particular mismatch with different efficiencies.

8. The method of claim 1, wherein said first and second strands are DNA.

9. The method of claim 1, wherein said mismatch is generated by a point mutation in the first strand or in the second strand.

10. The method of claim 1, wherein said mismatch is in one of the following genes:

CFTR, APC, p53, Rb, BRCA1, HMSH1, or HMLH1.

26. The method of claim 1, wherein said bacteriophage resolvases are purified resolvases.

27. The method of claim 1, wherein said first nucleic acid strand is human DNA.

28. The method of claim 1, wherein said first and said second bacteriophage resolvases are in two separate reaction mixtures.

29. The method claim 1, further comprising providing a plurality of said first strands.

30. The method of claim 1, further comprising providing a plurality of said second strands.

11. A method of detecting a mismatch between a first nucleic acid strand and a second nucleic acid strand comprising:

amplifying a portion of said first strand;

providing a plurality of said second strands;

forming a first duplex between an amplification product of said first strand and one of said second strands;

forming a second duplex between an amplification product of said first strand and one of said second strands;

contacting said first duplex with a first bacteriophage resolvase;

contacting said second duplex with a second bacteriophage resolvase, wherein said first and said second resolvases are different;

determining if at least one strand of said duplex is cleaved, cleavage being indicative of a mismatch.

12. A method of determining the location of a mismatch between a first nucleic acid strand and a second nucleic acid strand comprising:

forming a plurality of duplexes, each duplex including a molecule of said first nucleic acid strand, or a portion thereof, and a molecule of said second nucleic acid strand, or a portion thereof;

contacting a first bacteriophage resolvase and a second bacteriophage resolvase with said plurality of duplexes, wherein said first and said second resolvases are different;

determining the distance between the cleavage site and a second site on the strand (or the complement of the strand).

13. A method of determining the location of a mismatch between a first nucleic acid strand and a second nucleic acid strand comprising:

forming a first duplex between a molecule of said first strand, or a portion thereof, and a molecule of said second strand, or a portion thereof;

contacting said first duplex with a first bacteriophage resolvase;

forming a second duplex between a molecule of said first strand and a molecule of said second strand;

contacting said second duplex with a second bacteriophage resolvase wherein said first and said second resolvases are different;

determining the distance between the cleavage site and a second site on the strand (or the complement of the strand) by determining the size of a cleavage product, thereby determining the location of said mismatch.

14. The method of claim 13, wherein said first resolvase is contacted with said first duplex in a first reaction mixture and said second resolvase is contacted with said second duplex in a second reaction mixture.

15. The method of claim 13, wherein said first strand is derived from a subject at risk for a mutation and the second strand has a wild-type sequence for said mutation.

16. The method of claim 15, wherein said second strand is derived from the subject at risk for a mutation.

17. The method of claim 15, wherein said second strand is derived from a subject not at risk for a mutation or for a disorder associated with a mutation.

18. The method of claim 13, wherein said first bacteriophage resolvase is bacteriophage T4 endonuclease VII.

19. The method of claim 13, wherein said second bacteriophage resolvase is bacteriophage T7 endonuclease I.

20. The method of claim 13, wherein said first bacteriophage resolvase and said second bacteriophage resolvase cleave at a particular mismatch with different efficiencies.

21. The method of claim 13, wherein said first and second strands are DNA.

22. The method of claim 13, wherein said mismatch is generated by a point mutation in the first strand or in the second strand.

23. The method of claim 13, wherein said mismatch is in one of the following genes:

CFTR, APC, p53, Rb, BRCA1, HMSH1, or HMLH1.

24. An in vitro reaction mixture comprising:

a first purified bacteriophage resolvase;

a second purified bacteriophage resolvase, wherein said first and said second resolvases are different; and

a purified nucleic acid molecule.

25. A kit comprising:

a first purified bacteriophage resolvase;

a second purified bacteriophage resolvase, wherein said first and said second resolvases are different; and

a purified nucleic acid molecule.